166 related articles for article (PubMed ID: 19299048)
1. [Targeted therapies and their indications in solid neoplasias].
Dreyer C; Raymond E; Faivre S
Rev Med Interne; 2009 May; 30(5):416-24. PubMed ID: 19299048
[TBL] [Abstract][Full Text] [Related]
2. [Adverse effects of new oncologic therapies].
Weisshaupt Ch; Budak K; Pestalozzi B
Praxis (Bern 1994); 2011 Jul; 100(15):885-91; quiz 890. PubMed ID: 21792802
[No Abstract] [Full Text] [Related]
3. [Novelties in the treatment for advanced renal-cell cancer].
Maráz A
Orv Hetil; 2011 Apr; 152(17):655-62. PubMed ID: 21464023
[TBL] [Abstract][Full Text] [Related]
4. Treatment of patients with advanced neurofibromatosis type 2 with novel molecularly targeted therapies: from bench to bedside.
Subbiah V; Slopis J; Hong DS; Ketonen LM; Hamilton J; McCutcheon IE; Kurzrock R
J Clin Oncol; 2012 Feb; 30(5):e64-8. PubMed ID: 22203760
[No Abstract] [Full Text] [Related]
5. [Advanced renal carcinomas with special situations. How to treat them?].
Pouessel D; Patard JJ; Culine S
Bull Cancer; 2010; 97():83-90. PubMed ID: 20418207
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the systemic treatment of metastatic papillary renal cancer.
Chowdhury S; Choueiri TK
Expert Rev Anticancer Ther; 2009 Mar; 9(3):373-9. PubMed ID: 19275514
[TBL] [Abstract][Full Text] [Related]
7. [Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma].
Miller K; Bergmann L; Albers P; Gschwend J; Jäger E; Keilholz U
Aktuelle Urol; 2010 May; 41(3):193-6. PubMed ID: 20486036
[TBL] [Abstract][Full Text] [Related]
8. Signaling inhibitors in metastatic renal cell carcinoma.
Escudier B
Cancer J; 2008; 14(5):325-9. PubMed ID: 18836338
[TBL] [Abstract][Full Text] [Related]
9. [New possibilities of targeted therapy in the treatment of hepatocellular carcinoma with the help of molecular biology].
Hagymási K; Tulassay Z
Orv Hetil; 2010 Oct; 151(43):1763-8. PubMed ID: 20940115
[TBL] [Abstract][Full Text] [Related]
10. [Targeted therapies: sequential and combined treatments].
Gross-Goupil M; Escudier B
Bull Cancer; 2010; 97():65-71. PubMed ID: 20418205
[TBL] [Abstract][Full Text] [Related]
11. [Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma].
Miller K; Bergmann L; Jäger E; Jakse G; Wirth M; Keilholz U;
Aktuelle Urol; 2009 Jan; 40(1):27-30. PubMed ID: 19177318
[TBL] [Abstract][Full Text] [Related]
12. [Current aspects of second-line and sequence therapy of metastatic renal cell carcinoma].
Gschwend JE
Onkologie; 2010; 33 Suppl 1():10-1. PubMed ID: 20164670
[TBL] [Abstract][Full Text] [Related]
13. [Effect of angiogenesis inhibitors on renal cell carcinoma].
Bodrogi I
Magy Onkol; 2007; 51(2):145-53. PubMed ID: 17660871
[TBL] [Abstract][Full Text] [Related]
14. From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage.
Petrelli A; Giordano S
Curr Med Chem; 2008; 15(5):422-32. PubMed ID: 18288997
[TBL] [Abstract][Full Text] [Related]
15. Major treatment improvements encourage kidney cancer researchers to seek further gains.
Tuma RS
J Natl Cancer Inst; 2008 Sep; 100(17):1202-3. PubMed ID: 18728277
[No Abstract] [Full Text] [Related]
16. Sunitinib, sorafenib and mTOR inhibitors in renal cancer.
Radulovic S; Bjelogrlic SK
J BUON; 2007 Sep; 12 Suppl 1():S151-62. PubMed ID: 17935273
[TBL] [Abstract][Full Text] [Related]
17. [ASCO 2008. Bevacizumab in advanced renal carcinoma].
Mansueto G; Longo F
Tumori; 2008; 94(5):15-23. PubMed ID: 19112964
[No Abstract] [Full Text] [Related]
18. Prognostic factors in patients treated with VEGF-targeted therapies.
Choueiri TK
Clin Adv Hematol Oncol; 2010 Feb; 8(2):92-3. PubMed ID: 20386528
[No Abstract] [Full Text] [Related]
19. Promising systemic therapy for renal cell carcinoma.
Cooney MM; Remick SC; Vogelzang NJ
Curr Treat Options Oncol; 2005 Sep; 6(5):357-65. PubMed ID: 16107239
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapies in metastatic renal cancer in 2009.
Bastien L; Culine S; Paule B; Ledbai S; Patard JJ; de la Taille A
BJU Int; 2009 May; 103(10):1334-42. PubMed ID: 19338565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
